Implications for employers: The White House press release and news reports remain vague about pricing for employer sponsored health plans - so employers should watch closely to see the impact on their acquisition costs
You may see your blood sugar improve within a few days to weeks
Source [14] GLP-1 medication usage by age in the U.S
She can move without pain, so she can be more active and keep healthier habits
A 2024 analysis of ~87,000 appointments found patients had 64% higher odds of completing telehealth visits compared to in-person likely because theres no transportation barrier, less time off work, and more scheduling flexibility
By Distribution Channel)- Global Market Size, Share, Growth, Trends, Statistics Analysis Report, By Region And Segment Forecasts 20242032 Market Overview The glucagon-like peptide 1 (GLP-1) agonist market size was valued at USD 10.8 Billion in 2023 and is expected to reach a market size of USD 21.2 Billion by 2032 at a CAGR of 7.8%